Telmisartan 40 mg Tablets

Adult dose

Administer 40 mg once daily orally with water, regardless of meal timing. Depending on the patient, 20 mg may also be effective once daily, and if necessary, the dosage can be increased up to 80 mg once daily. Maximum antihypertensive effect is typically achieved within 4 to 8 weeks after dosage increase. For the purpose of reducing cardiovascular disease risk, 80 mg once daily is recommended.

This medication can cause serious harm to the fetus and newborn when taken during pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Pregnant or potentially pregnant women and breastfeeding women should not take this medication. Patients with severely impaired liver function or biliary excretion issues should not take this medication. Patients with hypersensitivity or a history of certain hereditary angioedema should also avoid it. Diabetic patients with moderate to severe renal impairment should not use this medication in combination with agents containing aliskiren. Elderly patients or those with hyperkalemia, as well as patients with mild to moderate hepatic impairment, should use this medication cautiously, and dosage adjustments may be necessary. Patients with heart valve disease or ischemic heart disease should be cautious while taking this medication as it may cause excessively low blood pressure, leading to serious complications. Patients with gastrointestinal disorders should be careful due to the risk of gastrointestinal bleeding. Patients with renal artery hypertension or severe renal impairment should consult a physician before use due to the risk of worsening kidney function. Regular monitoring of blood pressure, kidney function, and serum potassium levels is necessary during treatment. Caution and dosage adjustments may be required when taken with other antihypertensive medications, especially ACE inhibitors, angiotensin II receptor antagonists, and aliskiren, due to the increased risk of hypotension, hyperkalemia, and renal dysfunction. This medication is not removed by dialysis; therefore, immediate medical attention is required in case of overdose. Side effects may include dizziness, hypotension, hyperkalemia, renal failure, angioedema, liver dysfunction, interstitial pneumonia, and rhabdomyolysis, so report any unusual symptoms to healthcare professionals promptly. Dizziness or fainting may occur when driving or operating machinery, so caution is advised. This medication contains sorbitol, so patients with hereditary fructose intolerance should avoid using it. Pregnant or breastfeeding women should avoid taking this medication; if it is absolutely necessary, consultation with a physician is required. Safety and efficacy in patients under 18 years of age have not been established and are not recommended. Keep this medication out of reach of children and do not transfer it to other containers.

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, dyspnea, angioedema (including fatal outcomes), anaphylactic reactions, anaphylactoid symptoms, severe rash with fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, liver dysfunction, hepatic impairment, yellowing of the skin (jaundice), generalized malaise, sudden and severe headache, paralysis, severe neurological symptoms, renal failure (including acute renal failure)

Mild side effects

• Upper respiratory tract infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain the storage temperature between 1°C and 30°C at room temperature.

Appearance

White or almost white, double convex round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle